Metropolis Healthcare changes terms of acquisition of Hitech Diagnostic to full cash

Earlier on January 17, 2021, Metropolis Healthcare had approved the acquisition of Hitech Diagnostic Centre and its arm Centralab Healthcare Services in a combination of cash and equity shares deal.

At that time, it was cash consideration of Rs 511 crore and equity consideration of up to 4,95,000 fully paid-up equity shares of Rs 2 each.

Now the terms have been changed and it’s a full cash consideration of Rs 636 crore.

It’s unclear what has resulted in the changed terms.

However, in terms of financial implication, doesn’t seem much different. As per January terms, it would have been a total consideration of about Rs 622 crore (based on Meteropolis share price then). Now it’s Rs 636 crore, so not much different.


Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x